Triconal
Alternative Names: Anti-CMV MAbLatest Information Update: 13 Mar 1995
At a glance
- Originator Unknown
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 13 Mar 1995 No-Development-Reported for Cytomegalovirus infections in USA (Unknown route)